Usefulness of α7 Nicotinic Receptor Messenger RNA Levels in Peripheral Blood Mononuclear Cells as a Marker for Cholinergic Antiinflammatory Pathway Activity in Septic Patients: Results of a Pilot Study
Usefulness of α7 Nicotinic Receptor Messenger RNA Levels in Peripheral Blood Mononuclear Cells as a Marker for Cholinergic Antiinflammatory Pathway Activity in Septic Patients: Results of a Pilot Study
复制标题
DOI:
10.1093/infdis/jiu425
复制
发表时间:
2015-01-01
影响因子:
6.4
通讯作者:
Montiel, Carmen
中科院分区:
文献类型:
--
作者:
Cedillo, Jose L.;Arnalich, Francisco;Montiel, Carmen
Background. Stimulation of the vagus nerve in the so-called cholinergic antiinflammatory pathway (CAP) attenuates systemic inflammation, improving survival in animal sepsis models via alpha 7 nicotinic acetylcholine receptors on immunocompetent cells. Because the relevance of this regulatory pathway is unknown in human sepsis, this pilot study assessed whether the alpha 7 gene expression level in septic patients' peripheral blood mononuclear cells (PBMC) might be used to assess CAP activity and clinical outcome.Methods. The PBMCs alpha 7 messenger RNA levels were determined by real-time quantitative reverse-transcription polymerase chain reaction in 33 controls and 33 patients at enrollment and after their hospital discharge. Data were analyzed to find significant associations between alpha 7 level, vagally mediated heart rate variability as an indirect reflection of CAP activity, serum concentrations of different inflammation markers, and clinical course.Results. Septic patients' alpha 7 levels were significantly increased and returned to control values after recovery. These alpha 7 levels correlated directly with the vagal heart input and inversely with the magnitude of the patient's inflammatory state, disease severity, and clinical outcome.Conclusions. This study reveals that the PBMC alpha 7 gene expression level is a clinically relevant marker for CAP activity in sepsis: the higher the alpha 7 expression, the better the inflammation control and the prognosis.